Uses, dosage, & side effects
The Low Dose is 1.6 mg (5 units), containing 1 mg GHK-Cu and 200 mcg each of BPC-157, TB-4, and KPV
Side effects: GLP-1 medications are frequently associated with nausea, constipation, gastroparesis, and, in some patients, significant muscle mass loss alongside fat loss
In rare instances, repeated injections of certain lipotropic components have led to inflammation or small nodules forming under the skin at the injection site
The beta-3 adrenergic pathway that AOD 9604 activates is highly expressed in visceral adipose tissue, making it a targeted tool for belly fat reduction